Business · 28/04/2022Updated: 10/17/2026 · 1 min read
FDA Seeks Public Comment on Expanded Access to Investigational Drugs for Treatment Use
Summary
The Food and Drug Administration (FDA) is requesting public comment on a proposed collection of information for review and clearance under the Paperwork Reduction Act of 1995, which aims to expand access to investigational drugs for treatment use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →